Steady Growth Supports J&J’s Wide Moat
January 26, 2016 at 11:38 AM EST
Headwinds from the firm’s drug business shouldn't derail strong returns over the long run, says Morningstar’s Damien Conover.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.